Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-01-19 | 2024-03-22 | 216653 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-11-27 | 2023-03-16 | 175901 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-12-09 | 2023-03-16 | 177606 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-10-27 | 2024-01-05 | 208417 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-11-06 | 2024-01-05 | 209336 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-11-24 | 2024-01-05 | 211481 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-08-22 | 2024-11-01 | 235692 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-03-05 | 2019-04-05 | 77875 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-12-08 | 2023-12-15 | 212937 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-08-12 | 2023-08-18 | 201696 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2022-05-27 | 2022-09-30 | 161448 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-10-20 | 2023-11-10 | 207719 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-01-09 | 2019-02-13 | 71659 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-05-19 | 2023-07-27 | 192806 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2024-04-26 | 2024-06-28 | 226318 |
| APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2024-07-12 | 2024-09-06 | 232821 |
| APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2023-04-14 | 2023-07-07 | 189653 |
| APO-ELETRIPTAN | 40MG | TABLET TABLET | Resolved | 2020-09-02 | 2021-11-19 | 123558 |
| APO-ELETRIPTAN | 20MG | TABLET | Resolved | 2017-03-10 | 2020-01-07 | 305 |
| APO-ELETRIPTAN | 20MG | TABLET TABLET | Resolved | 2020-11-26 | 2022-06-03 | 128925 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP OPH SOLN 0.25% | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |